Export 14 results:
Autore [ Titolo] Tipo Anno Filtri: Autore è Tricarico, Paola Maura [Clear All Filters]
Alendronate, a double-edged sword acting in the mevalonate pathway. Mol Med Rep 2015;12(3):4238-42.
. Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line. Inflammopharmacology 2018;26(1):285-290.
. . Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. Int J Mol Sci 2014;15(4):6843-56.
. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Molecules 2014;19(12):21127-53.
. GRID2 a novel gene possibly associated with mevalonate kinase deficiency. Rheumatol Int 2015;35(4):657-9.
. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency. Cell Physiol Biochem 2017;41(4):1649-1660.
. Lopinavir/Ritonavir Treatment Induces Oxidative Stress and Caspaseindependent Apoptosis in Human Glioblastoma U-87 MG Cell Line. Curr HIV Res 2018;16(2):106-112.
. Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. Int J Dev Neurosci 2012;30(6):451-6.
. Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link. Int J Mol Sci 2015;16(7):16067-84.
. Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency. Apoptosis 2015;20(8):1048-55.
. Putative modifier genes in mevalonate kinase deficiency. Mol Med Rep 2016;13(4):3181-9.
.